Business Wire - December 13, 2002

There are over 850,000 nonprofits in the United States,and amfAR was one of only 13 national health organizations that Worth ultimately selected as most deserving of philanthropic support in its article "To Give Well, Give Wisely."

"We are honored to be included in Worth magazine's annual '100 Best Charities' issue for the second year in a row," said amfAR's Chief Executive Officer, Jerome J. Radwin. "I believe this distinction reflects our dedication to fostering and championing innovation in the foundation's programs to fight HIV/AIDS."

In its December 2002 issue, Worth reports: "Since 1985, amfAR has funded AIDS research. Its grantees have made major breakthroughs, including synthesizing the precursor to T-20 (also known as Fuzeon), a drug likely to win FDA approval soon. Current research projects include identifying new treatment options for patients who have developed a resistance to existing drugs and developing vaccines and microbicides. Asia is expected to be the next epicenter of AIDS, and amfAR is pushing for improvements in the health care infrastructure there and in medical providers' knowledge about AIDS. The new amfAR Global Link report, the first international compendium of HIV/AIDS clinical trials, is available online."

"We hope that Worth's examination and findings about our organization will encourage others to support amfAR in its lifesaving mission," said amfAR CEO Jerome J. Radwin.

In compiling this year's list, Worth set out to find 100 nonprofits that have shown the greatest efficiency and effectiveness in advancing their missions and to see how those groups spend the money invested in them. The magazine reports: "(W)e are confident that the charities on this list will spend your money wisely and will do their best to change some of the grim facts of today's world that we all face."

The American Foundation for AIDS Research (amfAR) is the nation's leading nonprofit organization dedicated to the support of AIDS research, AIDS prevention, treatment education, and the advocacy of sound AIDS-related public policy. Since 1985, amfAR has invested nearly $190 million in support for its programs and awarded grants to over 1,900 research teams worldwide.

CONTACT: American Foundation for Aids Research, New York

Deborah Hernan, 212/806-1744, deborah.hernan@amfar.org

SOURCE: American Foundation for AIDS Research

021213
BW021205

Copyright © 2002 - Business Wire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Business Wire, Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854. http://www.businesswire.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .